Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) HKSE
41.34
-1.34(-3.14%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
41.34
-1.34(-3.14%)
Currency In HKD
| Market Cap | 32.9B |
| Enterprise Value | 32.6B |
| P/E Ratio | 53.95 |
| PEG Ratio | 0.44 |
| Price/Sales Ratio | 6.06 |
| Price/Book Ratio | 2.29 |
| Enterprise/Revenue | 6.02 |
| Enterprise/EBITDA | 28.94 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.13 |
| Operating Margin | 0.15 |
| Return On Assets | 0.03 |
| Return On Equity | 0.04 |
| Revenue | 6.83B |
| Revenue/Share | 8 |
| Gross Profit | 1.87B |
| EBITDA | 1.42B |
| Net Income | 887.89M |
| Diluted EPS | 1.03 |
| Total Cash | 1.84B |
| Total Cash/Share | 2.15 |
| Total Debt | 1.47B |
| Total Debt/Equity | 0.07 |
| Current Ratio | 2.18 |
| Book Value Per Share | 28.41 |
| 52-Week Change | 54.54 |
| 52-Week High | 60.6 |
| 52-Week Low | 24.55 |
| Moving Average 50 Days | 43.83 |
| Moving Average 200 Days | 46.25 |
| Average Volume | 1.84M |
| Shares Outstanding | 1.21B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.3 |
| Trailing Annual Dividend Yield | 0.53 |
| Payout Ratio | 0.31 |
| Last Split Factor | N/A |
| Last Split Date | N/A |